Document and Entity Information
Document and Entity Information - shares | 6 Months Ended | |
Feb. 29, 2020 | May 28, 2021 | |
Document And Entity Information | ||
Entity Registrant Name | China WuYi Mountain, Ltd. | |
Entity Central Index Key | 0001687065 | |
Document Type | 10-Q | |
Document Period End Date | Feb. 29, 2020 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --08-31 | |
Entity Interactive Data Current | No | |
Is Entity an Emerging Growth Company | false | |
Is Entity a Small Business | true | |
is Entity a Shell Company | false | |
Is Entity's Reporting Status Current? | No | |
Entity Incorporation, State or Country Code | NV | |
Entity File Number | 333-21426 | |
Entity Filer Category | Non-accelerated Filer | |
Entity Common Stock, Shares Outstanding | 85,600,000 | |
Document Fiscal Period Focus | Q2 | |
Document Fiscal Year Focus | 2020 |
CONDENSED BALANCE SHEETS (Unaud
CONDENSED BALANCE SHEETS (Unaudited) - USD ($) | Feb. 29, 2020 | Aug. 31, 2019 |
CURRENT ASSETS | ||
Cash | $ 1,073 | $ 1,169 |
Other receivable (Note 4) | 20,000 | 20,000 |
TOTAL CURRENT ASSETS | 21,073 | 21,169 |
CURRENT LIABILITIES | ||
Accounts payable | 9,092 | 8,498 |
Due to related party (Note 4) | 46,249 | 46,249 |
TOTAL CURRENT LIABILITIES | 55,341 | 54,747 |
STOCKHOLDERS' EQUITY' (DEFICIT) | ||
Capital stock (Note 3) Authorized 2,000,000 shares of preferred stock, $0.001 par value, Issued and outstanding - nil | 0 | 0 |
Capital stock (Note 3) 200,000,000 shares of common stock, $0.001 par value, Issued and outstanding 85,600,000 shares of common stock (85,600,000 - August 31, 2019) | 85,600 | 85,600 |
Subscription receivable | (50,000) | (50,000) |
Additional paid in capital | 89,491 | 89,491 |
Accumulated deficit | (159,359) | (158,669) |
TOTAL STOCKHOLDERS' EQUITY (DEFICIT) | (34,268) | (33,578) |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | $ 21,073 | $ 21,169 |
CONDENSED BALANCE SHEETS (Una_2
CONDENSED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares | Feb. 29, 2020 | Aug. 31, 2019 |
STOCKHOLDERS' EQUITY (DEFICIT) | ||
Common stock, par value | $ 0.001 | $ 0.001 |
Common stock, authorized | 200,000,000 | 200,000,000 |
Common stock, issued | 85,600,000 | 85,600,000 |
Common stock, outstanding | 85,600,000 | 85,600,000 |
Preferred stock, par value | $ 0.001 | $ 0.001 |
Preferred stock, authorized | 2,000,000 | 2,000,000 |
Preferred stock, issued | 0 | 0 |
Preferred stock, outstanding | 0 | 0 |
CONDENSED STATEMENTS OF OPERATI
CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Feb. 29, 2020 | Feb. 28, 2019 | Feb. 29, 2020 | Feb. 28, 2019 | |
Income Taxes Details | ||||
REVENUE | $ 0 | $ 0 | $ 0 | $ 0 |
EXPENSES | ||||
Office and general | 345 | 498 | 690 | 797 |
Consulting fees | 0 | 3,000 | 0 | 16,403 |
Professional fees | 0 | 13,700 | 0 | 13,700 |
TOTAL EXPENSES | 345 | 17,198 | 690 | 30,900 |
Other Income | 0 | 0 | 0 | 0 |
NET LOSS | $ (345) | $ (17,198) | $ (690) | $ (30,900) |
BASIC NET LOSS PER COMMON SHARE | $ 0 | $ 0 | $ 0 | $ 0 |
WEIGHTED AVERAGE NUMBER OF BASIC COMMON SHARES OUTSTANDING | 85,600,000 | 85,600,000 | 85,600,000 | 85,600,000 |
CONDENSED STATEMENTS OF STOCKHO
CONDENSED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($) | Common Stock | Additional Paid-In Capital | Subscription Receivable | Accumulated Deficit | Total |
Beginning balance, Shares at Aug. 31, 2018 | 85,600,000 | ||||
Beginning balance, Amount at Aug. 31, 2018 | $ 85,600 | $ 89,491 | $ (50,000) | $ (112,323) | $ 12,768 |
Net loss | (13,702) | (13,702) | |||
Ending balance, Shares at Nov. 30, 2018 | 85,600,000 | ||||
Ending balance, Amount at Nov. 30, 2018 | $ 85,600 | 89,481 | (50,000) | (126,025) | (934) |
Net loss | (17,198) | (17,198) | |||
Ending balance, Shares at Feb. 28, 2019 | 85,600,000 | ||||
Ending balance, Amount at Feb. 28, 2019 | $ 85,600 | 89,481 | (50,000) | (143,223) | (18,132) |
Beginning balance, Shares at Aug. 31, 2019 | 85,600,000 | ||||
Beginning balance, Amount at Aug. 31, 2019 | $ 85,600 | 89,491 | (50,000) | (158,669) | (33,578) |
Net loss | (345) | (345) | |||
Ending balance, Shares at Nov. 30, 2019 | 85,600,000 | ||||
Ending balance, Amount at Nov. 30, 2019 | $ 85,600 | 89,491 | (50,000) | (159,014) | (33,923) |
Net loss | (345) | (345) | |||
Ending balance, Shares at Feb. 29, 2020 | 85,600,000 | ||||
Ending balance, Amount at Feb. 29, 2020 | $ 85,600 | $ 89,491 | $ (50,000) | $ (159,359) | $ (34,268) |
CONDENSED STATEMENTS OF CASH FL
CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) | 6 Months Ended | |
Feb. 29, 2020 | Feb. 28, 2019 | |
OPERATING ACTIVITIES | ||
Net loss for the period | $ (690) | $ (30,900) |
Changes in operating assets and liabilities: | ||
Increase (decrease) in accounts payable | 594 | 3,372 |
Accounts receivable | 0 | (20,000) |
NET CASH USED IN OPERATING ACTIVITIES | (96) | (47,528) |
CASH FLOW FROM INVESTING ACTIVITIES | 0 | 0 |
CASH FLOW FROM FINANCING ACTIVITIES | ||
Related party advances | 0 | 7,749 |
NET CASH PROVIDED BY FINANCING ACTIVITIES | 0 | 7,749 |
NET INCREASE (DECREASE) IN CASH | (96) | (39,779) |
CASH, BEGINNING | 1,169 | 40,885 |
CASH, ENDING | 1,073 | 1,106 |
SUPPLEMENTAL CASH FLOW INFORMATION AND NONCASH FINANCING ACTIVITIES; | ||
Cash paid during the period for Interest | 0 | 0 |
Cash paid during the period for Income taxes | 0 | 0 |
Related party debt forgiveness | $ 0 | $ 0 |
NATURE OF OPERATIONS AND BASIS
NATURE OF OPERATIONS AND BASIS OF PRESENTATION | 6 Months Ended |
Feb. 29, 2020 | |
Notes to Financial Statements | |
NATURE OF OPERATIONS AND BASIS OF PRESENTATION | NOTE 1 – NATURE OF OPERATIONS AND BASIS OF PRESENTATION KOKOS GROUP INC. was incorporated in the State of Nevada as a for-profit Company on July 26, 2016 and established a fiscal year end of August 31. The Company is organized to bottle, market, distribute and sell our own brand of coconut water, presently called “Koos Coconut Water”. On November 10, 2017 the Board of directors and the majority of its shareholders of Kokos Group Inc., amended the Company’s current Certificate of Incorporation in conformity with the applicable laws of the State of Nevada to change the name of the Company from Kokos Group Inc. to China Wu Yi Mountain Ltd. On May 24, 2018 FINRA approved the Company’s corporate action changing the Company’s name and trading symbol effective May 25, 2018. On October 19, 2017 Mr. Lei Wang became its Chief Executive Officer, Chief Financial Officer and sole Director and Mr. Richard Rappaprt was appointed Secretary. In addition, Mr. Baterina and Messrs. Flemming H.H. Hansen and Arthur T. Claravall submitted his resignations from all executive officer positions with the Company, including Chief Executive Officer and President effective October 19, 2017, and each submitted their resignation as a member of the Board. On January 18, 2018, Richard Rappaport submitted his resignation as Secretary of Kokos Group Inc. (the "Company"), effective immediately. On the same day, Ying Zhang was appointed Secretary, effective immediately. Going concern The financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. To date the Company has generated no revenues from its business operations and has incurred operating losses since inception of $159,359. As at February 29, 2020, the Company has working capital deficit of 34,268. The Company requires additional funding to meet its ongoing obligations and to fund anticipated operating losses. The ability of the Company to continue as a going concern is dependent on raising capital to fund its initial business plan and ultimately to attain profitable operations. Accordingly, these factors raise substantial doubt as to the Company’s ability to continue as a going concern. The Company intends to continue to fund its business by way of private placements and advances from related parties as may be required. As of August 31, 2018, the Company has issued 800,000,000 founders shares at $0.0000125 per share for net proceeds of $10,000 to the Company and private placements of 25,600,000 common shares at $0.000375 per share for net proceeds of $9,600. On May 2, 2018, the Company entered into a subscription agreement with a China-based company, Grand Biotechnology Group Liaoning, (the authorized signor for Grand Biotechnology is a 4.9% shareholder of the Company), for the issuance of an aggregate of 20,000,000 shares of restricted common stock at $0.0075 per share for an aggregate purchase price of U.S.$150,000. On May 15, 2018 the Company had received $100,000. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 6 Months Ended |
Feb. 29, 2020 | |
Notes to Financial Statements | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles for financial information and with the instructions to Form 10-Q. They do not include all information and footnotes required by United States generally accepted accounting principles for complete financial statements. However, except as disclosed herein, there has been no material changes in the information disclosed in the notes to the financial statements for the fiscal year ended August 31, 2019 included in the Company’s 10-K filed with the Securities and Exchange Commission on May 10, 2021. The unaudited financial statements should be read in conjunction with those financial statements included in the Form 10-K. In the opinion of Management, all adjustments considered necessary for a fair presentation, consisting solely of normal recurring adjustments, have been made. Operating results for the six months ended February 29, 2020 are not necessarily indicative of the results that may be expected for the year ending August 31, 2020. Segmented Reporting FSAB ASC 280, “Disclosure about Segments of an Enterprise and Related Information”, changed the way public companies report information about segments of their business in their quarterly reports issued to shareholders. It also requires entity-wide disclosures about the products and services the entity provides, the material countries in which it holds assets and reports revenues and its major customers. Comprehensive Loss “Reporting Comprehensive Income,” establishes standards for the reporting and display of comprehensive loss and its components in the financial statements. As at February 29, 2020 the Company has no items that represent a comprehensive loss and, therefore, has not included a schedule of comprehensive loss in the financial statements. Use of Estimates and Assumptions Preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Accordingly, actual results could differ from those estimates. Cash and Cash Equivalents For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. Revenue Recognition The Company recognizes revenue in accordance with ASC topic 605 “Revenue Recognition, and other applicable revenue recognition guidance under US GAAP. Sales revenue is recognized for our retail and wholesale customers when: (i) persuasive evidence of a sales arrangement exists, (ii) the sales terms are fixed or determinable, (iii) title and risk of loss have transferred, and (iv) collectability is reasonably assured — generally when products are shipped to the customer and services are rendered, except in situations in which title passes upon receipt of the products by the customer. Revenue consists of revenue earned for the sale of organic coconut water and services provided by the Company. Revenue is recognized at the time the product is shipped to the customer and or services provided by the Company are fulfilled. Financial Instruments All significant financial assets, financial liabilities and equity instruments of the Company are either recognized or disclosed in the financial statements together with other information relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. Where practical the fair values of financial assets and financial liabilities have been determined and disclosed; otherwise only available information pertinent to fair value has been disclosed. Loss per Common Share The basic earnings (loss) per share is calculated by dividing the Company’s net income available to common shareholders by the weighted average number of common shares during the year. The diluted earnings (loss) per share is calculated by dividing the Company’s net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. Diluted earnings (loss) per share are the same as basic earnings (loss) per share due to the lack of dilutive items in the Company. Income Taxes The Company follows the liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax balances and tax loss carry-forwards. Deferred tax assets and liabilities are measured using enacted or substantially enacted tax rates expected to apply to the taxable income in the years in which those differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the date of enactment or substantive enactment. Stock-based Compensation The Company follows ASC 718-10, "Stock Compensation", which addresses the accounting for transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus on transactions in which an entity obtains employee services in share-based payment transactions. ASC 718-10 is a revision to SFAS No. 123, "Accounting for Stock-Based Compensation," and supersedes Accounting Principles Board ("APB") Opinion No. 25, "Accounting for Stock Issued to Employees," and its related implementation guidance. ASC 718-10 requires measurement of the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). Incremental compensation costs arising from subsequent modifications of awards after the grant date must be recognized. The Company has not adopted a stock option plan and has not granted any stock options. As at February 29, 2020 the Company had not adopted a stock option plan nor had it granted any stock options. Accordingly, no stock-based compensation has been recorded to date. Recent Accounting Pronouncements The Company’s management has evaluated all the recently issued, but not yet effective, accounting standards that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these financial statements and does not believe the future adoption of any such pronouncements will have a material effect on the Company’s financial position and results of operations. |
CAPITAL STOCK
CAPITAL STOCK | 6 Months Ended |
Feb. 29, 2020 | |
Notes to Financial Statements | |
CAPITAL STOCK | NOTE 3 – CAPITAL STOCK The Company’s capitalization is 200,000,000 common shares with a par value of $0.001 per share and 2,000,000 preferred shares with a par value of $0.001 per share. Total shares issued as of February 29, 2020 are 85,600,000 common shares and no preferred shares have been issued. On May 2, 2018, the Company entered into a subscription agreement with a China-based company, Grand Biotechnology Group Liaoning, (the authorized signor for Grand Biotechnology is a 4.9% shareholder of the Company), for the issuance of an aggregate of 20,000,000 shares of restricted common stock at $0.0075 per share for an aggregate purchase price of U.S.$150,000. On May 2, 2018, the Company issued 20,000,000 shares of restricted common stock. On May 15, 2018 the Company had received $100,000. As of February 29, 2020 $50,000 unpaid stock purchased amount are recorded as “ Subscription receivable “ under stockholders’ equity on the balance sheet. As of February 29, 2020, the Company has not granted any stock options and has not recorded any stock-based compensation. As of February 29, 2020, the Company issued 0 shares of preferred stock and 85,600,000 common shares are issued and outstanding. |
OTHER RECEIVABLE
OTHER RECEIVABLE | 6 Months Ended |
Feb. 29, 2020 | |
Notes to Financial Statements | |
OTHER RECEIVABLE | NOTE 4 – OTHER RECEIVABLE On December 12, 2018 the Company advanced $20,000 to China Dahongpao Hong Kong Co. Ltd. For legal work and due diligence investigation on a potential merger/consolidation. If the potential merger/consolidation is abandoned by China Dahongpao Hong Kong Co. Ltd., the funds will be payable by December 31, 2021. The amounts owed by the party are unsecured and non-interest bearing. |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 6 Months Ended |
Feb. 29, 2020 | |
Notes to Financial Statements | |
RELATED PARTY TRANSACTIONS | NOTE 5 – RELATED PARTY TRANSACTIONS During the period ended August 31, 2019 Century Acquisitions advance $20,000 and paid outstand invoice for $1,749. The amounts due to the related party are unsecured and non- interest-bearing with no set terms of repayment. As of February 29, 2020 the balance of due to related party is $46,249 (August 31, 2019 - $46,249). The amounts due to the related party are unsecured and non- interest-bearing with no set terms of repayment. |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 6 Months Ended |
Feb. 29, 2020 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | NOTE 6 – SUBSEQUENT EVENTS During April and May 2021, Century Acquisition (Formerly WP Acquisition Company, LLC), a 19.25% shareholder, paid outstanding invoices on behalf of the Company for $21,976. The amounts due to the related party are unsecured and non- interest-bearing with no set terms of repayment. |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 6 Months Ended |
Feb. 29, 2020 | |
Notes to Financial Statements | |
Basis of Presentation | Basis of Presentation The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles for financial information and with the instructions to Form 10-Q. They do not include all information and footnotes required by United States generally accepted accounting principles for complete financial statements. However, except as disclosed herein, there has been no material changes in the information disclosed in the notes to the financial statements for the fiscal year ended August 31, 2019 included in the Company’s 10-K filed with the Securities and Exchange Commission on May 10, 2021. The unaudited financial statements should be read in conjunction with those financial statements included in the Form 10-K. In the opinion of Management, all adjustments considered necessary for a fair presentation, consisting solely of normal recurring adjustments, have been made. Operating results for the six months ended February 29, 2020 are not necessarily indicative of the results that may be expected for the year ending August 31, 2020. |
Segmented Reporting | Segmented Reporting FSAB ASC 280, “Disclosure about Segments of an Enterprise and Related Information”, changed the way public companies report information about segments of their business in their quarterly reports issued to shareholders. It also requires entity-wide disclosures about the products and services the entity provides, the material countries in which it holds assets and reports revenues and its major customers. |
Comprehensive Loss | Comprehensive Loss “Reporting Comprehensive Income,” establishes standards for the reporting and display of comprehensive loss and its components in the financial statements. As at February 29, 2020 the Company has no items that represent a comprehensive loss and, therefore, has not included a schedule of comprehensive loss in the financial statements. |
Use of Estimates and Assumptions | Use of Estimates and Assumptions Preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Accordingly, actual results could differ from those estimates. |
Cash and Cash Equivalents | Cash and Cash Equivalents For purposes of the statement of cash flows, the Company considers highly liquid financial instruments purchased with a maturity of three months or less to be cash equivalents. |
Revenue Recognition | Revenue Recognition The Company recognizes revenue in accordance with ASC topic 605 “Revenue Recognition, and other applicable revenue recognition guidance under US GAAP. Sales revenue is recognized for our retail and wholesale customers when: (i) persuasive evidence of a sales arrangement exists, (ii) the sales terms are fixed or determinable, (iii) title and risk of loss have transferred, and (iv) collectability is reasonably assured — generally when products are shipped to the customer and services are rendered, except in situations in which title passes upon receipt of the products by the customer. Revenue consists of revenue earned for the sale of organic coconut water and services provided by the Company. Revenue is recognized at the time the product is shipped to the customer and or services provided by the Company are fulfilled. |
Financial Instruments | Financial Instruments All significant financial assets, financial liabilities and equity instruments of the Company are either recognized or disclosed in the financial statements together with other information relevant for making a reasonable assessment of future cash flows, interest rate risk and credit risk. Where practical the fair values of financial assets and financial liabilities have been determined and disclosed; otherwise only available information pertinent to fair value has been disclosed. |
Loss per Common Share | Loss per Common Share The basic earnings (loss) per share is calculated by dividing the Company’s net income available to common shareholders by the weighted average number of common shares during the year. The diluted earnings (loss) per share is calculated by dividing the Company’s net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. Diluted earnings (loss) per share are the same as basic earnings (loss) per share due to the lack of dilutive items in the Company. |
Income Taxes | Income Taxes The Company follows the liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax balances and tax loss carry-forwards. Deferred tax assets and liabilities are measured using enacted or substantially enacted tax rates expected to apply to the taxable income in the years in which those differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the date of enactment or substantive enactment. |
Stock-based Compensation | Stock-based Compensation The Company follows ASC 718-10, "Stock Compensation", which addresses the accounting for transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus on transactions in which an entity obtains employee services in share-based payment transactions. ASC 718-10 is a revision to SFAS No. 123, "Accounting for Stock-Based Compensation," and supersedes Accounting Principles Board ("APB") Opinion No. 25, "Accounting for Stock Issued to Employees," and its related implementation guidance. ASC 718-10 requires measurement of the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). Incremental compensation costs arising from subsequent modifications of awards after the grant date must be recognized. The Company has not adopted a stock option plan and has not granted any stock options. As at February 29, 2020 the Company had not adopted a stock option plan nor had it granted any stock options. Accordingly, no stock-based compensation has been recorded to date. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements The Company’s management has evaluated all the recently issued, but not yet effective, accounting standards that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these financial statements and does not believe the future adoption of any such pronouncements will have a material effect on the Company’s financial position and results of operations. |
NATURE OF OPERATIONS AND BASI_2
NATURE OF OPERATIONS AND BASIS OF PRESENTATION (Details Narrative) - USD ($) | May 02, 2018 | Feb. 29, 2020 | Feb. 28, 2019 | Feb. 28, 2018 | Aug. 31, 2019 |
Date of incorporation | Jul. 26, 2016 | ||||
State of incorporation | NV | ||||
Working capital deficit | $ (34,268) | ||||
Accumulated Deficit | $ (159,359) | $ (158,669) | |||
Common stock, issued | 800,000,000 | ||||
Issuance of common shares, per share | $ 0.0000125 | ||||
Subscription Agreement [Member] | Grand Biotechnology Group Liaoning [Member] | |||||
Stock issued during period, shares, restricted stock | 20,000,000 | ||||
Stock issued during period, value, restricted stock | $ 150,000 | ||||
Share Price | $ 0.0075 | ||||
Private Placement [Member] | |||||
Common stock, issued | 25,600,000 | ||||
Issuance of common shares, per share | $ 0.000375 | ||||
Proceeds from sale of common stock | $ 9,600 |
CAPITAL STOCK (Details Narrativ
CAPITAL STOCK (Details Narrative) - USD ($) | May 02, 2018 | Feb. 29, 2020 | Aug. 31, 2019 |
Common stock, par value | $ 0.001 | $ 0.001 | |
Common stock, authorized | 200,000,000 | 200,000,000 | |
Common stock, issued | 85,600,000 | 85,600,000 | |
Common stock, outstanding | 85,600,000 | 85,600,000 | |
Common stock cash proceeds | $ 100,000 | ||
Preferred stock, par value | $ 0.001 | $ 0.001 | |
Preferred stock, authorized | 2,000,000 | 2,000,000 | |
Preferred stock, issued | 0 | 0 | |
Preferred stock, outstanding | 0 | 0 | |
Common stock value | $ 85,600 | $ 85,600 | |
Subscription receivable | $ (50,000) | $ (50,000) | |
Subscription Agreement [Member] | Grand Biotechnology Group Liaoning [Member] | |||
Stock issued during period, shares, restricted stock | 20,000,000 | ||
Stock issued during period, value, restricted stock | $ 150,000 | ||
Share Price | $ 0.0075 |
OTHER RECEIVABLE (Details Narra
OTHER RECEIVABLE (Details Narrative) | Dec. 12, 2018USD ($) |
Notes to Financial Statements | |
Other receivable | $ 20,000 |
RELATED PARTY TRANSACTIONS (Det
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($) | 6 Months Ended | |
Feb. 29, 2020 | Aug. 31, 2019 | |
Due to related party | $ 46,249 | $ 46,249 |
Shareholder [Member] | WP Acquisition Company, LLC [Member] | ||
Due to related party | 20,000 | |
Payment for invoice | $ 1,749 |
SUBSEQUENT EVENTS (Details Narr
SUBSEQUENT EVENTS (Details Narrative) - USD ($) | May 31, 2021 | Feb. 29, 2020 | Aug. 31, 2019 |
Due to related party | $ 46,249 | $ 46,249 | |
Subsequent Event [Member] | Shareholder [Member] | Century Acquisition [Member] | |||
Due to related party | $ 21,976 | ||
Due to related party in percentage | 19.25% |